beta-L-Fucp-(1->6)-beta-D-GlcpNAc

Term ID

CHEBI:152409

Synonyms

2-acetamido-2-deoxy-6-O-(6-deoxy-beta-L-galactopyranosyl)-beta-D-glucopyranose
2-acetamido-2-deoxy-6-O-(beta-L-fucopyranosyl)-beta-D-glucopyranose
6-deoxy-beta-L-galacto-hexopyranosyl-(1->6)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose
Fuc(b1-6)b-GlcNAc
N-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-[[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]acetamide
WURCS=2.0/2,2,1/[a2122h-1b_1-5_2*NCC/3=O][a1221m-1b_1-5]/1-2/a6-b1

Definition

An amino disaccharide consisting of beta-L-fucopyranose and 2-acetamido-2-deoxy-beta-D-glucopyranose residues joined in sequence by a (1->6) glycosidic bond.

References

GlyGen:G61843VN
GlyTouCan:G61843VN

Ontology

ChEBI ( EBI )

Relationships

is a type of: acetamides amino disaccharide glycosylglucose derivative

acetamides amino disaccharide glycosylglucose derivative Show first 5 Terms
has_functional_parent: beta-L-fucose N-acetyl-beta-D-glucosamine

beta-L-fucose N-acetyl-beta-D-glucosamine Show first 5 Terms

Phenotype

Phenotype resulting from beta-L-Fucp-(1->6)-beta-D-GlcpNAc

Phenotype where environments contain beta-L-Fucp-(1->6)-beta-D-GlcpNAc

Phenotype modified by environments containing beta-L-Fucp-(1->6)-beta-D-GlcpNAc

Human Disease Model